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The biogenesis and function of the mitochondrial
respiratory chain (RC) involve the organization of
RC enzyme complexes in supercomplexes or respi-
rasomes through an unknown biosynthetic process.
This leads to structural interdependences between
RC complexes, which are highly relevant from
biological and biomedical perspectives, because
RC defects often lead to severe neuromuscular
disorders. We show that in human cells, respirasome
biogenesis involves a complex I assembly interme-
diate acting as a scaffold for the combined incorpo-
ration of complexes III and IV subunits, rather than
originating from the association of preassembled
individual holoenzymes. The process ends with the
incorporation of complex I NADH dehydrogenase
catalytic module, which leads to the respirasome
activation. While complexes III and IV assemble
either as free holoenzymes or by incorporation of
free subunits into supercomplexes, the respira-
somes constitute the structural units where complex
I is assembled and activated, thus explaining the
significance of the respirasomes for RC function.
INTRODUCTION
The mammalian oxidative phosphorylation (OXPHOS) system is
formed by five multiprotein enzyme complexes and two mobile
electron carriers (ubiquinone and cytochrome c) embedded in
the mitochondrial inner membrane. Complexes I–IV (CI–CIV)
form the respiratory chain (RC), which facilitates electron transfer
from reducing equivalents to molecular oxygen coupled to
proton pumping across the inner membrane. The proton
gradient generated is subsequently used by complex V to drive
ATP synthesis. With the exception of CII subunits that are all en-
coded by the nuclear genome, the remaining OXPHOS enzymes
contain subunits of dual genetic origin, nuclear and mitochon-
drial. Nuclear DNA (nDNA)-encoded subunits are synthesized
on cytosolic ribosomes and imported into mitochondria, where
they assemble together with mitochondrial DNA (mtDNA)-324 Cell Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc.encoded subunits and prosthetic groups to build up OXPHOS
complexes with the assistance of specific chaperones or
assembly factors (Fernandez-Vizarra et al., 2009).
The structural and functional organization of the RC has been
a matter of debate for more than 50 years. Two models have
been historically hypothesized. Following the ‘‘fluid state’’
model, individual OXPHOS complexes diffuse freely in the mito-
chondrial inner membrane and electron transport occurs when
the complexes randomly collide (Hackenbrock et al., 1986).
Conversely, the ‘‘solid state’’ model proposes that OXPHOS
complexes are organized in rigid higher-order assemblies
(Chance and Williams, 1955) known as supercomplexes or
respirasomes (Schagger and Pfeiffer, 2000). It is currently
accepted that both organizations probably coexist, giving rise
to the ‘‘dynamic aggregate’’ or ‘‘plasticity’’ model. This model
suggests that OXPHOS complexes switch from freely moving
to fixed structures and vice versa to adapt to changes in cellular
metabolism (Acin-Perez et al., 2008). Accordingly, the co-
existence of the respirasome unit, composed of at least
CI+CIII+CIV, together with free CIII and CIV has been widely
described (Althoff et al., 2011; Dudkina et al., 2011; Heinemeyer
et al., 2007; Schafer et al., 2006; Schagger and Pfeiffer, 2000).
However, the association of complexes II and V with the respira-
somes remains controversial (Acin-Perez et al., 2008; Wittig and
Schagger, 2009). It has been suggested that association of RC
complexes in respirasomes may offer structural or functional
advantages, such as the prevention of their destabilization and
degradation, the enhancement of electron transport efficiency
and substrate channeling, or the decrease of electron or proton
leakages (Lenaz and Genova, 2010). As a consequence of their
organization in supercomplexes, a structural interdependence
exists among the individual OXPHOS complexes (Acin-Perez
et al., 2004; Diaz et al., 2006; Li et al., 2007; Schagger et al.,
2004; Soto et al., 2009). This has major biological as well as
biomedical implications, since RC enzyme assembly defects
produce severe encephalomyopathies and neurodegenerative
disorders in human and have been associated with the aging
process. In human mitochondrial diseases, structural alterations
primarily affecting one given complex often induce pleiotropic
deleterious effects of the other enzymes. For instance, patho-
genic mutations in CIII subunits or assembly genes lead to pleio-
tropic deficiencies of CI and CIV in affected tissues (Fernandez-
Vizarra et al., 2007; Lamantea et al., 2002; Moran et al., 2010),
mutations in CIV subunits may lead to secondary CI deficiencies
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Figure 1. Steady-State Levels of Mitochondrial
Supercomplexes in Human Cell Lines
Sixty micrograms of isolated mitochondria were analyzed
by 2D-BN/SDS-PAGE. Western blot analysis was per-
formed using antibodies against the indicated OXPHOS
subunits. SC, supercomplexes containing CI, CIII, and
CIV; CI*, partially assembled CI; CIII2, complex III dimer;
CIV*, putative CIV dimer; III2+IV, supercomplex containing
CIII and CIV. See also Table S1 and Figures S1 and S2.
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Assembly of Human Mitochondrial Supercomplexes(D’Aurelio et al., 2006), andmutations affecting CI-specific genes
can produce combined CI and CIII, or CI and CIV, deficiencies
in patients (Budde et al., 2000; Saada et al., 2011).
The mechanisms that regulate the biosynthesis of mitochon-
drial supercomplexes remain unsolved. Pulse-chase experi-
ments that analyzed the time course incorporation of the 13
mtDNA-encoded proteins into RC complexes and supercom-
plexes suggested that the latter originate by the direct associa-
tion of single preassembled complexes (Acin-Perez et al.,
2008). However, the observation that newly imported nDNA-
encoded CIV subunits were preferentially integrated into super-
complexes in the absence of monomeric holo-CIV suggested
that the formation of these macromolecular assemblies does
not necessarily require the preassembly of individual holocom-
plexes, but could also be achieved through a coordinated
association of partially assembled complexes and free subunits
(Lazarou et al., 2009).
In the present study we have addressed the biosynthetic
pathway of mitochondrial RC supercomplexes by partially
depleting control cell lines of OXPHOS complexes by treatment
with doxycycline, a reversible inhibitor of mitochondrial transla-
tion. The synthesis of mtDNA-encoded subunits resumed after
drug removal, and we subsequently investigated their time
course incorporation into supercomplex assembly intermedi-
ates. Based on the analyses of the composition and function
of these intermediates, we propose a multistep model for mito-
chondrial supercomplex assembly. It involves three sequential
basic steps: (1) formation of aCI assembly intermediate; (2) incor-
poration of CIII andCIV subunits and subassemblies; and (3) final
assembly of CI by incorporation of the NADH dehydrogenase
catalytic core and subsequent functional respirasome acti-
vation. This model allows us to explain the requirements for CI
assembly, the structural interdependences among OXPHOS
complexes, and why certain genetic defects affecting a single
complex may lead to combined RC enzyme defects in patients.
RESULTS
Distribution of RC Subunits in Mitochondrial Complexes
and Supercomplexes
We analyzed the relative distribution of individual RC subunits
between large supercomplexes I+III2+IVn (SC); small supercom-Cell Metabolism 15,plexes (III2+IV); and free RC complexes I (CI), III
(CIII2), and IV (CIV) in three common human
control cell lines (143B206 osteosarcoma cells,
HEK293 embryonic kidney cells, and control
transmitochondrial cybrids). Blue native gel
electrophoresis (2D-BN/SDS-PAGE) in combi-nation with western blot analysis showed comparable protein
contents and distribution patterns of all tested RC subunits in
the three control cell lines (Figure 1). Between 65% and 97%
of the signals corresponding to CI subunits were localized in
supercomplexes larger than 1,500 kDa (SC). The NDUFA9
and NDUFS2 subunits also colocalized in a spot (indicated as
CI*) that corresponds to a stable 830 kDa subcomplex. The
NDUFA9, NDUFS2, and NDUFS4 subunits were additionally
detected at reduced levels in lower bands that resemble the
previously reported pattern of CI subcomplexes (Antonicka
et al., 2003; Lazarou et al., 2007; Ugalde et al., 2004a; Vogel
et al., 2007a). Concerning CIII subunits, 50% of CORE2 and
Rieske iron-sulfur protein (RISP) was detected in large I+III2+IVn
supercomplexes, 40% in free CIII homodimers, and 5%–
10% in supercomplex III2+IV. In contrast, 30% of the signals
corresponding to the CIV COX1 and COX5A subunits was
detected in I+III2+IVn supercomplexes, 65%–70% in free
holo-CIV, and only traces (1%–3%) in supercomplex III2+IV.
The signal corresponding to the SDHA subunit appeared mainly
at the complex II position (CII), with no clear colocalization with
supercomplexes. These results are comparable to those re-
ported in other mammalian cell lines or tissues (Schagger and
Pfeiffer, 2001). The signals obtained from three independent
western blots per cell line were quantified and expressed as
percentages of the total signal obtained from each antibody
(see Table S1 available with this article online). The CIII RISP
and CIV COX1 subunits were50% less abundant within super-
complex III2+IV than their respective partners CORE2 and
COX5A. Likewise, the RISP subunit was 20% less abundant
than CORE2 within supercomplex I+III2+IVn, whereas COX1
was 25% more abundant than COX5A. These results suggest
stoichiometric variations among RC subunits of the same
complex within the different supercomplex forms.
Effects of Doxycycline Treatment in Mitochondrial
Translation and RC Assembly
These variations in the distribution patterns of subunits from the
same RC complex could be explained by differences in either
the assembly kinetics or the stability of these subunits within
the supercomplexes. To discriminate between these two possi-
bilities, we depleted cells of mtDNA-encoded subunits contain-
ing OXPHOS complexes and supercomplexes by treating the324–335, March 7, 2012 ª2012 Elsevier Inc. 325
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Figure 2. Incorporation Rates of Individual
Complex I Subunits in Supercomplexes
(A) Example of 2D-BN/SDS-PAGE western blot
analysis in doxycycline-treated 143B cells using
antibodies against the indicated CI subunits.
(B) Mean incorporation rates of CI subunits in large
supercomplexes (SC). The signals corresponding
to CI subunits were quantified in duplicate gels
per cell line and normalized by the CII SDHA
subunit. a.d.u., arbitrary densitometric units. Mean
values are expressed as percentages relative to
untreated cells (SS). Error bars represent standard
deviations (SD). Abbreviations are as in Figure 1.
See also Figure S3.
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Assembly of Human Mitochondrial Supercomplexescultures with doxycycline, a reversible inhibitor of mitochondrial
translation. This strategy was successfully used to follow the
assembly kinetics of CI (Ugalde et al., 2004a; Pello et al.,
2008). We cultured the 143B cells and control cybrids for
6 days and the HEK293 cells for 8 days in the presence of
15 mg/ml doxycycline. Longer treatments affected cell viability
(Ugalde et al., 2004a). Real-time PCR analyses showed that
doxycycline induced a partial loss (35%–40%) of mtDNA
molecules, which recovered back to normal levels 96 hr after
the treatment. Additionally, doxycycline severely inhibited
mitochondrial protein synthesis in 143B cells without affecting
overall cytoplasmic translation, although a 10%–15% residual
synthesis of mitochondrial polypeptides was detectable after
quantification (Figure S1). The sporadic mtDNA loss did not
further affect mitochondrial translation, since the expression
of mitochondrial polypeptides recovered normal levels 72 hr
after doxycycline treatment.
To follow the accumulation of newly synthesized RC
complexes and their further association into supercomplexes,
samples were collected at different time points (0, 6, 15, 24,
48, 72, and 96 hr) after doxycycline removal. Digitonin-solubi-
lized mitochondrial particles were separated by BN-PAGE and
analyzed by western blot. In agreement with the residual
synthesis of mtDNA-encoded subunits, we detected an 80%
reduction of CIII and CIV and a lack of fully assembled CI
(see 0 hr, Figure S2). These residual amounts were not sufficient326 Cell Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc.to sustain the formation of supercom-
plexes, in agreement with previous
studies suggesting that respirasome
assembly proceeds when individual
complexes III and IV have accumulated
above a critical threshold (D’Aurelio
et al., 2006). CII levels were normal after
doxycycline treatment, as expected since
this complex lacks mtDNA-encoded
subunits.
Assembly Kinetics of Complex I
Subunits in Mitochondrial
Supercomplexes
Mammalian CI biogenesis consists of
a semisequential pathway that involves
the preassembly and further association
of evolutionarily conserved functionalmodules (Ugalde et al., 2004a). To follow CI assembly and incor-
poration into supercomplexes, samples from doxycycline treat-
ment recovery experiments were separated by 2D-BN/SDS-
PAGE, and blots were probed with antibodies that recognize
subunits representative of different CI assembly stages (McKen-
zie and Ryan, 2010). NDUFS2 is an early assembly subunit that
forms subcomplexes of the peripheral arm ubiquinone reduction
(or Q) module; NDUFA9 is an intermediate assembly subunit
that is thought to be located in the boundary between the
peripheral arm and the hydrophobic membrane arm (or P
module); and NDUFV1 and NDUFS4 are constituents of the
peripheral arm NADH dehydrogenase (or N) catalytic module
that are crucial to the final steps of CI assembly. After 6 days
of doxycycline treatment (0 hr in Figure 2A), we did not detect
any of the tested CI subunits within the I+III2+IVn supercomplex.
At this time, residual amounts of NDUFA9 and NDUFS2 accu-
mulated in spots previously reported as CI subassemblies
(Ugalde et al., 2004a; Vogel et al., 2007a). One common spot
(indicated as CI*) corresponded to the stable subcomplex of
830 kDa that lacked the NDUFS4 and NDUFV1 subunits,
both of which are part of the CI N module. This subcomplex
constitutes a physiological CI assembly intermediate that
accumulates in cells from patients with pathogenic mutations
in the NDUFS1, NDUFS4, and NDUFV1 genes (Hoefs et al.,
2010; Lazarou et al., 2007; Ugalde et al., 2004b; Vogel et al.,
2007b). As the translation of mitochondrial proteins restarted,
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Figure 3. Assembly Kinetics of Individual Complex III Subunits in Supercomplexes
(A) Example of 2D-BN/SDS-PAGE western blot analysis in doxycycline-treated 143B cells using antibodies against the indicated CIII subunits.
(B) Densitometric histogram representing the assembly progress of the CORE2 and RISP subunits in CIII-containing structures.
(C) Mean incorporation rates of CORE2 and RISP subunits in CIII-containing structures. The signals were quantified in duplicate gels per cell line and normalized
by CII. CIII2, complex III dimer (left panel); III2+IV, supercomplex containing CIII and CIV (middle panel); SC, supercomplexes containing CI, CIII and CIV (right
panel). (a.d.u.), arbitrary densitometric units. Mean values are expressed as percentages relative to untreated cells (SS). Error bars represent standard deviations
(SD). See also Figure S3.
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Assembly of Human Mitochondrial Supercomplexesthe CI* subcomplex moved toward the position of the large I+III2
or I+III2+IVn supercomplexes and disappeared 72–96 hr after
doxycycline removal, indicating that it could be a supercomplex
assembly intermediate. Accumulation of the NDUFA9 and
NDUFS2 proteins in supercomplexes started to be detected
around 15–24 hr after doxycycline removal and reached maxi-
mum levels at time 96 hr. However, the NDUFS4 and NDUFV1
subunits appeared in such structures between 48 and 72 hr after
removing the drug, indicating that the initial incorporations of
these two subunits within the supercomplexes were delayed
in comparison with the NDUFA9 and NDUFS2 subunits. These
data suggest that at early supercomplex assembly stages CI
is neither fully assembled nor active when it binds to other
RC complexes, since it lacks part of the N module catalytic
subunits. The NDUFS4 subunit reached its maximum steady-
state levels at time 96 hr, indicating that despite its initial delay,
this subunit gets rapidly integrated into supercomplexes.
However, the NDUFV1 subunit showed much lower levels at
96 hr, indicating a marked delay in its incorporation into super-
complexes. A quantitative estimation of the assembly rates for
the different CI subunits is shown in Figure 2B.CeAssembly Kinetics of Complex III Subunits in
Mitochondrial Supercomplexes
Although CIII assembly has not been well studied in mammals,
a model for the biosynthetic pathway of this complex has been
proposed in yeast (Zara et al., 2009). Based on this model, we
analyzed the integration into CIII of an early assembly accessory
subunit (CORE2) and a late-assembly catalytic subunit (RISP)
and their further incorporations into the native supercomplex
species III2+IV, I+III2 and I+III2+IVn (the latter two indicated as
SC in Figures 3A–3C). After 6 days of doxycycline treatment
(0 hr), we observed an 80%–90% reduction in the amounts
of CORE2 and RISP subunits within the CIII dimer (CIII2)
compared to untreated cells (SS in Figure 3B). The accumulation
of both subunits within CIII2 increased gradually after the trans-
lation of mtDNA-encoded proteins resumed; the CORE2 protein
reached maximum steady-state levels after 24–48 hr, and the
RISP subunit did so after 72–96 hr. These data confirmed that
in human cells, the RISP subunit also gets assembled at a late
stage of CIII assembly. Low levels of the CORE2 protein
appeared in the III2+IV and I+III2+IVn supercomplexes around
24–48 hr after doxycycline removal, reaching its maximumll Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc. 327
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Figure 4. Assembly Kinetics of Individual Complex IV Subunits in Supercomplexes
(A) Example of 2D-BN/SDS-PAGE western blot analysis in doxycycline-treated 143B cells using antibodies against the indicated CIV subunits.
(B) Mean incorporation rates of CIV subunits in CIV-containing structures. The signals were quantified in duplicate gels per cell line and normalized by CII. CIV,
complex IV (left panel); III2+IV, supercomplex containing CIII and CIV (middle panel); SC, supercomplexes containing CI, CIII, and CIV (right panel); CIV*, putative
complex IV dimer; a.d.u., arbitrary densitometric units. Mean values correspond to percentages relative to untreated cells (SS). Error bars represent standard
deviations (SD). See also Figure S3.
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Assembly of Human Mitochondrial Supercomplexessteady-state levels at 96 hr (Figure 3 and Figure S3A). The incor-
poration of RISP within the I+III2+IVn supercomplexes was
delayed compared to CORE2, since it appeared 48 hr after
doxycycline removal, keeping low levels (30%–50% of the
steady state) after 96 hr. These data indicate that at early super-
complex assembly stages CIII is neither fully assembled nor
active, since it lacks at least the RISP subunit. Surprisingly,
RISP started appearing within the III2+IV supercomplex at time
96 hr, suggesting that the III2+IV supercomplex gets fully assem-
bled after the formation of the I+III2+IVn supercomplexes.
Assembly Kinetics of Complex IV Subunits in
Mitochondrial Supercomplexes
We next analyzed the incorporation of four subunits involved
in early steps of human CIV assembly (two mtDNA-encoded
catalytic subunits, COX1 and COX2, and two nDNA-encoded
structural subunits, COX4 and COX5A) and that of a late-
assembly structural subunit (COX6C) into holo-CIV, and into328 Cell Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc.the III2+IV and I+III2+IVn supercomplexes (Fornuskova et al.,
2010; Nijtmans et al., 1998) (Figure 4A). The quantification of
CIV signals from BN experiments showed that after 6 days of
doxycycline treatment (0 hr) there was an 90% reduction in
the amounts of all COX subunits within holo-CIV compared
with the untreated cells (SS) (Figure 4B). The incorporation rates
of all subunits within CIV increased steadily after restarting
mitochondrial translation and reached maximum steady-state
levels at least 96 hr following doxycycline removal. These data
confirmed our previous results suggesting that in control human
cells, fully assembled CIV is restored later than CI and CIII (Pello
et al., 2008). The COX4 and COX5A subunits started getting
incorporated into the I+III2+IVn and III2+IV supercomplexes
24–48 hr after doxycycline removal (Figure 4 and Figure S3B).
In contrast, the COX1, COX2, and COX6C subunits appeared
in the I+III2+IVn supercomplexes after 48–72 hr, indicating a
delayed incorporation of these three subunits in the large super-
complexes. As shown in Figure 4B, these subunits followed
Cell Metabolism
Assembly of Human Mitochondrial Supercomplexesdifferent incorporation rates into I+III2+IVn supercomplexes,
since COX2 steady-state levels were fully restored 96 hr after
doxycycline removal, while COX1 and COX6C levels remained
low (40%–50% of the steady state). The COX1, COX2, and
COX6C subunits were first detected in the III2+IV supercomplex
at time 96 hr. As for CIII, these data indicate that CIV is neither
fully assembled nor active when its subunits and intermediates
bind other RC complexes to form supercomplexes, and confirm
that the biosynthesis of the I+III2+IVn supercomplexes precedes
the formation of the III2+IV supercomplex.
Assembly Kinetics of RC Subunits into Mitochondrial
Supercomplexes
To obtain a comprehensive view of the supercomplex assembly
pathway, we performed a comparative analysis of the incorpo-
ration rates of all tested RC subunits into the large I+III2+IVn
supercomplexes (Figure 5 and Figure S3C). Our results showed
that CI NDUFA9 and NDUFS2 subunits were initially stabilized
in a CI subassembly (CI*, Figure 2) lacking the catalytic N
module, which constitutes the first supercomplex assembly
intermediate (SC1). In BN gels, this intermediate started moving
toward the position of the I+III2+IVn supercomplexes around
24 hr after doxycycline removal, in parallel with the incorpora-
tion of CIII CORE2 subunit and CIV COX4 and COX5A subunits,
reaching maximum levels at time 96 hr (Figure S3C). These
data imply the formation of a second supercomplex assembly
intermediate (SC2) composed of partially assembled CI with
incorporated CIII and CIV subunits or subassemblies (Fig-
ure 5A). The CI NDUFS4 and CIV COX2 subunits first appeared
in I+III2+IVn supercomplexes around 48 hr after removing the
drug but rapidly reached their maximum levels. These data
indicate that the incorporation of these two RC subunits within
the large supercomplexes occurs in a third assembly stage
(SC3). The catalytic CIII RISP and CIV COX1 subunits, and
the structural CIV subunit COX6C, appeared at low levels in
I+III2+IVn supercomplexes after 48–72 hr, but these levels re-
mained low at time 96 hr, indicating a slower incorporation of
these three subunits in a fourth supercomplex assembly stage
(SC4). Due to the low relative abundance of COX1 and COX6C
within supercomplexes at time 96 hr, we cannot differentiate
which of these two CIV subunits gets inserted first. This is
compatible with a model in which COX1 could get assembled
before the final bulk of COX subunits to complete the super-
complex structures. Finally, the catalytic CI subunit NDUFV1
started appearing in I+III2+IVn supercomplexes after 48–72 hr,
but its assembly kinetics were markedly slower than that of
the RISP, COX1, and COX6C subunits, indicating that NDUFV1
incorporates into supercomplexes in a fifth assembly stage
(SC5).
Based on these results, RC supercomplexes should get acti-
vated in parallel with the incorporation of the last catalytic
subunits (between 48 and 72 hr after doxycycline removal). To
confirm this hypothesis, we analyzed samples by BN-PAGE
followed by CI and CIV in-gel activity (IGA) assays (Figure 5B).
After 6 days of doxycycline treatment (Figure 5B, 0 hr), we
observed a virtual absence of CI and CIV activities within super-
complexes (indicated as SCa) compared to untreated cells (SS,
Figure 5B). Densitometric analyses of the IGA assays (Figure 5C)
showed that the enzymatic activities of both complexes startedCeincreasing gradually in supercomplexes48 hr after doxycycline
removal without reaching their maximum activities after 96 hr,
in parallel with the incorporation of the NDUFV1 and COX1
subunits. This result was confirmed by spectrophotometric
measurements of rotenone-sensitive CI NADH dehydrogenase
activity (Figure 5D).
Altered Assembly of Mitochondrial Supercomplexes
in COX2 Mutant Cybrids
To verify our supercomplex assembly model, we investigated
the effect of pathogenic mutations that affect the assembly of
single RC complexes in the formation of supercomplexes. We
analyzed a 143B mutant cybrid carrying the homoplasmic
m.7896 G > A mutation in the COX2 gene, described in a CIV-
deficient patient (Campos et al., 2001). BN-IGA assays showed
severe reductions of CI and CIV enzyme activities in the mutant
cybrids compared to an isogenic control (Figure 6A). Western
blot analyses of duplicate BN gels showed that the mutants
lacked both fully assembled CIV and COX-containing super-
complexes, although they accumulated the I+III2 supercomplex
and CIII dimer (CIII2) (Figure 6A). Analyses by the sensitive 2D-
BN/SDS-PAGE method confirmed that mutant cybrids (M in
Figure 6B) completely lacked holo-CIV due to the absence of
COX2, as a consequence of which most of the remainder CIV
subunits were presumably degraded and those detected accu-
mulated as monomers or small CIV assembly intermediates.
This lack of CIV led to the absence of I+III2+IVn and III2+IV super-
complexes, and an accumulation of CIII2, the I+III2 supercom-
plex, and the 830 kDa supercomplex assembly intermediate
(CI* or SC1). We observed a severe reduction of the NDUFS4
and NDUFV1 subunits within the I+III2 supercomplex, in contrast
with the relative abundance of other CI subunits such as
NDUFA9 or NDUFS2 (Figure 6B). These results suggest that in
the absence of CIVmost I+III2 supercomplex is probably partially
assembled and inactive due to a hampered assembly or stability
of the NDUFS4 and NDUFV1 subunits. At longer exposures
(Figure S4A), the COX1 and COX4 subunits were detected at
low levels in the I+III2 supercomplex, although the COX5A and
COX6C subunits were not so clearly distinguished. These data
suggest that certain free COX subunits or subassemblies may
bind directly to supercomplex intermediates in the absence of
holo-CIV, as previously proposed (Lazarou et al., 2009).
The steady-state levels of CII were similar in COX2 mutant
and control cells and did not colocalize with supercomplexes
(Figure 6). After long exposures, CII traces that could represent
a supercomplex were detected in a high supramolecular struc-
ture (Figure S4B). However, the abundance and electrophoretic
mobility of this particular spot (indicated as SCII) was unaffected
by the lack of CIV in the mutant cell line. This result argues
against CII being a functional constituent of human I+III2+IVn
supercomplexes.
DISCUSSION
Weaimed to elucidate the biosynthetic pathway ofmitochondrial
supercomplexes, to better understand the molecular mecha-
nisms underlying the interdependences between RC complexes
that would aid explaining the severe RC assembly defects
found in patients with mitochondrial disorders. To address thell Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc. 329
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Figure 5. Comparative Analysis of the Incorporation Rates of RC Subunits into Large Supercomplexes
(A) Mean incorporation rates of RC subunits into I+III2+IVn supercomplexes (SC). SC2 represents the mean incorporation rates of NDUFA9, NDUFS2, CORE2,
COX4, and COX5A subunits into SC.
(B) Sixty micrograms of crude mitochondrial pellets from the doxycycline assays were analyzed by BN-PAGE in combination with in-gel activity (IGA) assays. The
left panel shows a CI IGA assay, where the * indicates unspecific bands with NADH dehydrogenase activity. The right panel shows a CIV IGA assay. ** indicates
the putative CIV dimer (CIV*) and supercomplex III2+IV that stained for CIV activity (CIVa). SCa indicates CI and CIV activities in large supercomplexes.
(C) Densitometric analysis of the CI and CIV SCa bands performed in three independent experiments.
(D) Spectrophotometric CI activities in digitonin-treated 143B cells. Triplicate measurements were normalized by the citrate synthase activity. a.d.u., arbitrary
densitometric units. Mean values represent percentages relative to untreated cells (SS). Error bars represent standard deviations (SD).
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Assembly of Human Mitochondrial Supercomplexesdynamics of assembly, we depleted control cell lines of OXPHOS
complexes by treatment with doxycycline to reversibly inhibit
mitochondrial translation, and upon drug removal we followed
complex and supercomplex assembly by BN-PAGE and immu-
nodetection. Based on the analyses of the assembly kinetics of330 Cell Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc.OXPHOS subunits, we propose a multistep model of mitochon-
drial supercomplex assembly (Figure 7). The conceptual novelty
of this model is that the biogenesis of the respirasome involves
the coordinated and sequential association of specific combina-
tions of partially assembled RC complexes and free subunits. In
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Figure 6. Analysis of Mitochondrial Supercomplexes in COX2 Mutant Cybrids
(A) BN-PAGE was performed inCOX2mutant cybrids carrying a homoplasmic m.7896 G > Amutation (M) and an isogenic control (C), followed by CI and CIV IGA
assays, or alternatively, blotted on nitrocellulose and incubated with the indicated antibodies.
(B) 2D-BN/SDS-PAGE western blot analysis in control (C) and the COX2 mutant (M) cybrids using antibodies against the indicated OXPHOS subunits.
Abbreviations are as in Figure 1. See also Figure S4.
Cell Metabolism
Assembly of Human Mitochondrial Supercomplexesa first stage, CIII and CIV assemble as individual entities until
reaching a threshold supposed to trigger the accumulation of
free subunits and assembly intermediates from these two
complexes. At this early stage, the assembly of CI probably
also starts taking place, in agreement with reports demon-
strating that the assembly of CI and CIII launch in parallel (Pello
et al., 2008), until building up a CI intermediate of 830 kDa
that lacks the NADH dehydrogenase module and perhaps addi-
tional subunits. Up to this stage, the pattern of CI subcomplexes
is in agreement with previous reports (Antonicka et al., 2003;
Lazarou et al., 2007; Ugalde et al., 2004a; Vogel et al., 2007a).
We propose that the 830 kDa CI subassembly actually consti-
tutes the first supercomplex assembly intermediate (SC1), sinceCeit remains in a stable competent state for the subsequent
combined incorporation of either individual subunits or subas-
semblies from CI, CIII, and CIV in at least five sequential
assembly steps (SC1–SC5 in Figure 7). The latest supercomplex
assembly step involves the association of catalytic subunits
from the CI NADH dehydrogenase module prior to the respira-
some activation cascade, although we cannot exclude addi-
tional intermediate steps between these two events. Our results
not only imply that SC1 is the core structure necessary for the
formation of the respirasomes but also that the respirasomes
constitute the structural units where CI gets fully assembled
and activated, thus explaining the essentiality of the respira-
somes for CI function (Schagger et al., 2004).ll Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc. 331
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Figure 7. Model for the Assembly of Mito-
chondrial Supercomplexes
In a first stage, the syntheses of fully assembled
and active CIII and CIV take place until reaching
a threshold that probably triggers the accumula-
tion of free subunits and assembly intermediates
from these two complexes. At this early stage the
assembly of CI also initiates (steps 1–6) to building
up a CI subassembly of 830 kDa that constitutes
the first supercomplex assembly intermediate
(SC1). This subcomplex remains in a stable
assembly competent state for the subsequent
binding of CIII subunit CORE2 and CIV subunits
COX4 and COX5A, to form a second super-
complex assembly intermediate (SC2). The
incorporations of CI NDUFS4 and CIV COX2
subunits, and maybe other free RC subunits or
subassemblies, take place in a third stage (SC3).
The catalytic CIII RISP and CIV COX1 subunits and
the structural CIV subunit COX6C incorporate to
the supercomplexes in a fourth stage (SC4). The
latest supercomplex assembly step involves the
association of catalytic subunits from the CI NADH
dehydrogenase module prior to the respirasome
activation (SC5).
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Assembly of Human Mitochondrial SupercomplexesThe mechanism we propose contrasts with the previously
suggested pathway based on the association of individual fully
assembled RC complexes (Acin-Perez et al., 2008). To demon-
strate their hypothesis, the authors analyzed the time course
incorporation of the 13 mtDNA-encoded OXPHOS proteins
into RC complexes and supercomplexes by BN-PAGE,
convincingly showing that there is a temporal gap between
the incorporation of mtDNA-encoded subunits into the indi-
vidual complexes and into supercomplexes. Our results agree
with this observation, but the additional analyses of nuclear-
encoded OXPHOS subunits provided here do not support the
interpretation that supercomplexes are formed by the ordered
association of preassembled complexes. The faster kinetics of
assembly of supercomplexes under their conditions is probably
due to the fact that a large pool of translated RC subunits
already exists in preassembled subcomplexes and supercom-
plex intermediates (Fernandez-Vizarra et al., 2009), which
remain in a competent state for the efficient channeling of newly
translated mtDNA-encoded subunits into assembly intermedi-332 Cell Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc.ates and subsequently in RC complexes
or supercomplexes. In our supercomplex
assembly model, the biogenesis of CIII
and CIV takes place prior to the forma-
tion of CI, which can only occur in the
context of the respirasome. In this re-
gard, our model does not contradict the
plasticity model, since it does not ex-
clude the assembly of holo-CIII and CIV
as independent pathways, but it ex-
cludes the formation of fully assembled
CI as an independent unit. Rather, we
propose that there are at least two regu-
latory steps in the biogenesis of the
OXPHOS system: first, the independentregulation of the assembly of individual holo-CIII and -CIV,
and second, the association of free CIII and CIV subunits or
subassemblies with a CI assembly intermediate to form the
respirasome. There must be additional regulatory steps, since
the functional meaning of intermediate supercomplex forms
remains unknown and deserve future attention. For example,
supercomplexes I+III2 or III2+IV could constitute either interme-
diate structures that would aid the assembly of newly synthe-
sized supercomplexes to adapt to changes in cellular metabo-
lism or maybe just supercomplex degradation products.
The current available literature regarding OXPHOS-deficient
patients and animal models supports the key steps of our respi-
rasome assembly model. It was described in human primary
fibroblasts that the 830 kDa CI intermediate (SC1) contains
most CI subunits, but neither NDUFS4 nor the subunits from
the N catalytic module (Lazarou et al., 2007). In agreement,
the 830 kDa intermediate is usually accumulated in patients’
fibroblasts with mutations in the CI NDUFS4 subunit (or mice
lacking this subunit) or in subunits from the N catalytic module,
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Assembly of Human Mitochondrial Supercomplexessuch as NDUFS1 or NDUFS6 (Calvaruso et al., 2011; Hoefs et al.,
2010; Kirby et al., 2004; Ugalde et al., 2004b). More importantly,
this 830 kDa subassembly has been found associated with
CIII subunits CORE1 and CORE2 in partially assembled super-
complexes from patients’ cells and mutant mice tissues (Calvar-
uso et al., 2011; Lazarou et al., 2007). Tissues from patients
harboring mutations in the BCS1L gene, involved in the
assembly of the RISP subunit into CIII, revealed the accumula-
tion of the CORE proteins in high-molecular-weight respirasome
intermediates that lacked the RISP protein in mutant but not
in wild-type cells, suggesting that these subunits could get
assembled into supercomplexes prior to the incorporation of
RISP (Fernandez-Vizarra et al., 2009). Mitochondria from pa-
tients in whom CIV biogenesis was compromised displayed a
preferential accumulation of certain CIV subunits in supercom-
plexes (Lazarou et al., 2009), as observed in our COX2 mutant
cybrids. These similarities between human and mice primary
cell cultures or tissues and the established cell lines shown in
our work support the generality in mammals of the respirasome
assembly mechanisms that we propose.
Our results concerning the composition of mitochondrial
supercomplexes in human control cell lines agree with previous
observations in other mammalian systems. Approximately 90%
of CI is associated with a CIII dimer (CIII2) and several CIV units
to form twomajor supercomplexes: I+III2 and I+III2+IV1-4 (Schag-
ger and Pfeiffer, 2001). In contrast,50%–60% of CIII and 70%–
80%of CIV remain individual, although both dynamically interact
in an intermediate III2+IV supercomplex. Incidentally, our data do
not support CII colocalization with mitochondrial supercom-
plexes. Tiny amounts of CII that migrated as a smear up to
400 kDa, below the CIII2 position, could correspond to CII trimers
as shown in bacteria (Sousa et al., 2011). Another tiny spot
detected in a supramolecular structure above supercomplex
I+III2+IVn could represent CII as a component of the mitoKATP
channel (Ardehali et al., 2004). None of these spots clearly colo-
calized with any RC complexes or supercomplexes. This is in
disagreement with a previous study based on coIP and BN anal-
yses and the same experimental conditions used here, which
claimed binding of some CII to supercomplexes (Acin-Perez
et al., 2008). These discrepancies could be due to technical
differences in the tissue-specific mitochondrial protein extrac-
tion methods or the electrophoretic conditions used, which
could affect the mobility of the samples. However, most studies
using techniques as diverse as BN-PAGE, single particle
electron microscopy, cryoelectron tomography, flux control
analyses, or studies based on time-dependent localization of
fluorescent RC subunits failed to show structural or functional
evidences supporting the presence of CII in mammalian RC
supercomplexes in normal physiological conditions (Dudkina
et al., 2011; Lenaz and Genova, 2010; Muster et al., 2010;
Quarato et al., 2011; Schafer et al., 2006; Schagger and Pfeiffer,
2000, 2001).
Importantly, our respirasome assembly model may explain
why certain genetic defects affecting a single complex lead to
combined RC enzyme deficiencies in patients. For instance, it
explains why CIV deficiences due to mutations in COX1 and
COX2 subunits lead to pleiotropic CI defects (this work and
D’Aurelio et al., 2006). The insertions of these two CIV subunits
into supercomplexes occur prior to or in parallel with the incor-Ceporation of subunits from the CI N catalytic module (NDUFV1
andNDUFS4). Consequently, the lack of COX1/COX2 or the total
absence of holo-CIV affects the assembly or stability of NDUFS4
and NDUFV1 within supercomplexes. This in turn leads to the
accumulation of the inactive 830 kDa supercomplex assembly
intermediate and a I+III2 intermediate that partially lacks the CI N
catalytic module, thus explaining the severe reduction in CI
activity detected in the COX mutant cells. A similar assembly
phenotype has been recently described in NDUFS4 knockout
mice (Calvaruso et al., 2011). The same argument serves to
explain why failures in the insertion of the CIII subunit RISP
may lead to secondary CI and CIV deficiencies in human tissues
(Fernandez-Vizarra et al., 2007; Moran et al., 2010).
The fact that CIII and CIV can get assembled either as indi-
vidual holoenzymes or by direct binding of free subunits to
supercomplex assembly intermediates supports the existence
of several independently regulated assembly pathways for the
biosynthesis of these two complexes. This would explain why
decreased CI levels do not usually lead to CIII and CIV assembly
and functional defects in mammals (Acin-Perez et al., 2004;
Schagger et al., 2004). Exceptions have been described in CI-
deficient patients with mutations in the NDUFS4 subunit (Budde
et al., 2000; Ugalde et al., 2004b) and C20ORF7 (Saada et al.,
2011), a mitochondrial methyltransferase involved in the
assembly or stability of an early CI assembly intermediate
(Sugiana et al., 2008). While the reason remains unclear, the
possibility exists that the CIII and CIV deficiencies observed in
these patients could be secondary phenomena. Alternatively,
NDUFS4 could function in the assembly or stability of individual
CIII, besides its role in supercomplex biogenesis. Similarly,
C20ORF7 could participate in the assembly or stability of
monomeric CIV, as well as in the posttranscriptional modif-
ication of proteins important for respirasome structural
stability. In this regard, C20ORF7 has been suggested to play
a role in the methylation of CI subunit NDUFB3, and it could
potentially modify additional OXPHOS components (Sugiana
et al., 2008).
Our model indirectly clarifies the possible roles of known
chaperones in the assembly of RC supercomplexes. The most
evident case is the NDUFAF2 (B17.2L) assembly factor, which
appears to function in a late stage of CI assembly. This protein
binds to the 830 kDa subcomplex and participates in the
insertion of the N module into CI (Ogilvie et al., 2005; Vogel
et al., 2007b). Because the 830 kDa subcomplex is a super-
complex assembly intermediate, and the insertion of the N
module is one of the last steps in the respirasome assembly
pathway, it seems appropriate to consider NDUFAF2 as the
first known supercomplex assembly factor. The roles of other
chaperones involved in late steps of CI assembly, or assembly
factors that regulate the biosynthesis of RC CIII and CIV, could
be also redefined within the frame of the supercomplex
assembly pathway described here.
Additional work is required to explain in detail the assembly
of all OXPHOS subunits into respirasomes, and to identify the
mechanisms that regulate the diverse biosynthetic pathways
for the formation of RC complexes and supercomplexes and
their modulation in response to environmental and physiological
conditions. Nonetheless, our model for supercomplexes
assembly represents a starting point to further elucidate thisll Metabolism 15, 324–335, March 7, 2012 ª2012 Elsevier Inc. 333
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Assembly of Human Mitochondrial Supercomplexesintricate process, and provides a framework to better under-
stand RC assembly defects in patients with mitochondrial
disorders.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture Conditions
Cybrids were constructed using the osteosarcoma 143B TK206 rho zero cell
line and enucleated control fibroblasts as described (King and Attardi, 1989).
Cells were cultured in high-glucose Dulbecco’s modified Eagle’s medium
(DMEM, Life Technologies) supplemented with 10% fetal calf serum (FCS),
2 mM L-glutamine, 1 mM sodium pyruvate, and antibiotics. To block mito-
chondrial translation, 15 mg/ml doxycycline was added to the culture medium.
Cells were grown in exponential conditions and harvested at the indicated
time points.
Quantification of mtDNA Copy Number
The relative quantification of mtDNA versus nDNA was performed by real-time
PCR in a HT 7500 Real-Time PCR System (Applied Biosystems) as previously
described (Pello et al., 2008).
Mitochondrial Protein Preparation
Mitochondrial pellets were isolated from cell cultures as described (Pello et al.,
2008). To prepare native mitochondrial proteins, pellets were solubilized in
200 ml buffer containing 1.5 M aminocaproic acid, 50 mM Bis-Tris (pH 7.0).
After optimizing solubilization conditions, we decided to use digitonin at
a concentration of 4 g/g protein. Solubilized samples were incubated on ice
for 15min and centrifuged for 30min at 13,000 rpmat 4C, and the supernatant
was combined with 20 ml of sample buffer (750 mM aminocaproic acid, 50 mM
Bis-Tris, 0.5 mM EDTA, 5% Serva Blue G-250) prior to loading.
Blue Native Electrophoresis and In-Gel Activity Assays
Blue native 3%–13% gradient gels were loaded with 60 mg of mitochondrial
protein and processed as described (Nijtmans et al., 2002). After electropho-
resis, proteins were transferred to a PROTAN nitrocellulose membrane
(Schleicher & Schuell) at 35 V overnight and probed with specific antibodies.
Duplicate gels were further used for IGA assays and for second-dimension
10% SDS-PAGE gels.
Antibodies
Western blot was performed using primary antibodies raised against the
following human OXPHOS subunits: NDUFV1 (Sigma), NDUFA9, NDUFS2,
NDUFS4, CORE2, RISP, COX1, COX2, COX4, COX5A, COX6C, and SDHA
(Mitosciences). Peroxidase-conjugated anti-mouse IgG was used as a
secondary antibody (Molecular Probes). The signal was detected with ECL
plus (Amersham Biosciences).
Spectrophotometric Assays
Rotenone-sensitive CI (NADH, ubiquinone oxidoreductase) activity was
measuredwith a DU-650 spectrophotometer (Beckman) at 37Cby incubating
150 mg of mitochondrial protein in 1 ml of assay medium (20 mM KP [pH 8.0],
0.1% BSA-EDTA, 100 mM CoQ1, 1 mM NaN3, 0.2 mM NADH without and
with 5 mM rotenone). The absorbance decrease at 340 nm due to the NADH
oxidation was measured and expressed as the percentage relative to the
citrate synthase activity.
Statistical Analysis
Densitometry was performed with the ImagePro-Plus 4.1 image analysis soft-
ware (Media Cybernetics). Graphs represent mean values of at least three
independent measurements. Error bars represent standard deviations (SD).
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